Sang Soo Kim

11PUBLICATIONS
26CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Microbial geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 11, 2025
Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer.

Dong Hoon Shin, Minyoung Choi, Chungyong Han

|Jan 18, 2025
Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors.

Hye Jung Baek, Geun Hee Han, Eun Joo Cho

|Sep 05, 2024
TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3.

Ki Sun Kim, Chanju Lee, Hyung-Seok Kim

|Aug 29, 2024
Galectin-9 Mediates the Functions of Microglia in the Hypoxic Brain Tumor Microenvironment.

Chanju Lee, Dahee Yu, Hyung-Seok Kim

|Oct 01, 2023
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.

Dong Hoon Shin, Jeong Yeon Jo, Minyoung Choi

|Nov 26, 2022
Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma.

Tae Hyun Kim, Sang Myung Woo, Woo Jin Lee

Pageof 2